These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25763581)

  • 1. [Evaluation of the effectiveness of exercise-based controlled physical effort in women with heart failure in the elderly].
    Andrzejczak-Karbowska M; Kapusta J; Inman M; Kowalski J; Irzmański R
    Pol Merkur Lekarski; 2015 Jan; 38(223):11-5. PubMed ID: 25763581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The impact of the dosing, a 12-week physical training on the concentration of NT-proBNP and D-Dimer in patients with heart failure and impaired functional capacity in VII-X decade of life].
    Andrzejczak-Karbowska M; Irzmański R
    Pol Merkur Lekarski; 2016 Jul; 41(241):11-15. PubMed ID: 27734814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of controlled physical activity as a method of therapy in patients with heart failure after invasive treatment of angina pectoris].
    Irzmański R; Kapusta J; Kowalski J
    Pol Merkur Lekarski; 2014 Aug; 37(218):77-81. PubMed ID: 25252439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
    Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
    Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise training in advanced heart failure patients: discordance between improved exercise tolerance and unchanged NT-proBNP levels.
    Arad M; Adler Y; Koren-Morag N; Natanzon S; Sela BA; Ben Dov I; Shechter M; Schwammenthal E; Freimark D
    Int J Cardiol; 2008 May; 126(1):114-9. PubMed ID: 17651845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can serum NT-proBNP detect changes of functional capacity in patients with chronic heart failure?
    Meyer T; Schwaab B; Görge G; Scharhag J; Herrmann M; Kindermann W
    Z Kardiol; 2004 Jul; 93(7):540-5. PubMed ID: 15243765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term residential cardiac rehabilitation reduces B-type natriuretic peptide.
    Berent R; von Duvillard SP; Crouse SF; Auer J; Green JS; Sinzinger H; Schmid P
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):603-8. PubMed ID: 19494782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of physical training on exercise capacity, gas exchange and N-terminal pro-brain natriuretic peptide levels in patients with chronic heart failure.
    Maria Sarullo F; Gristina T; Brusca I; Milia S; Raimondi R; Sajeva M; Maria La Chiusa S; Serio G; Paterna S; Di Pasquale P; Castello A
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):812-7. PubMed ID: 17001223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NT-proBNP in monitoring treatment of patients with congestive heart failure.
    Al-Meslmani BM; Fahoum SK; Shamia MG
    Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of controlled physical training in patients with acute coronary syndrome treated with intervention - assessment of effects on biochemical parameters and functional myocardial].
    Kapusta J; Kapusta A; Pawlicki L; Irzmański R
    Pol Merkur Lekarski; 2016 Jun; 40(240):351-6. PubMed ID: 27403900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
    Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
    Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].
    Yang CL; Qiu YR; Zhou F; Feng PF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):866-9. PubMed ID: 18504223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No effect of group-based aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure.
    Nilsson BB; Westheim A; Risberg MA; Arnesen H; Seljeflot I
    Scand Cardiovasc J; 2010 Aug; 44(4):223-9. PubMed ID: 20636229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
    Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of plasma NT-proBNP for diagnosing heart failure in patients with previous myocardial infarction].
    Wei BQ; Zhang J; Yang YJ; Lü R; Zhang YH; Zhou Q; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jan; 40(1):34-8. PubMed ID: 22490631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Bhardwaj A; Rehman SU; Mohammed A; Baggish AL; Moore SA; Januzzi JL
    Am Heart J; 2010 Apr; 159(4):532-538.e1. PubMed ID: 20362709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.